158 related articles for article (PubMed ID: 38193060)
1. Antiphospholipid syndrome in rural, remote, and First Nations peoples in the Top End of the Northern Territory, Australia.
Agbayani E; Doig C; Noutsos T
Res Pract Thromb Haemost; 2023 Nov; 7(8):102227. PubMed ID: 38193060
[TBL] [Abstract][Full Text] [Related]
2. Precipitating factors of catastrophic antiphospholipid syndrome: the role of anticoagulant treatment in a series of 112 patients.
Stammler R; Nguyen Y; Yelnik C; Le Guern V; Lambert M; Paule R; Hachulla E; Mouthon L; Dupré A; Ackermann F; Dufrost V; Wahl D; Godeau B; Leroux G; Benhamou Y; Lazaro E; Daugas E; Bezanahary H; Mekinian A; Piette JC; Morel N; Costedoat-Chalumeau N
J Thromb Haemost; 2023 May; 21(5):1258-1265. PubMed ID: 36792010
[TBL] [Abstract][Full Text] [Related]
3. [Case series and clinical analysis of 14 cases of catastrophic antiphospholipid syndrome].
Gu JY; Lu C; Shi H; Yang CD
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1033-1038. PubMed ID: 30562777
[TBL] [Abstract][Full Text] [Related]
4. A Retrospective Cohort Study of Red Cell Alloimmunisation in Rural, Remote, and Aboriginal and Torres Strait Islander Peoples Admitted to Intensive Care in the Northern Territory, Australia.
Noutsos T; Perry MA; Secombe PJ; Roxby DJ; Sinha R; Campbell LT
J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836141
[TBL] [Abstract][Full Text] [Related]
5. Ferritin in the antiphospholipid syndrome and its catastrophic variant (cAPS).
Agmon-Levin N; Rosário C; Katz BS; Zandman-Goddard G; Meroni P; Cervera R; Stojanovich L; Blank M; Pierangeli S; Praprotnik S; Meis Ed; Seguro LP; Ruffatti A; Pengo V; Tincani A; Doria A; Shoenfeld Y
Lupus; 2013 Nov; 22(13):1327-35. PubMed ID: 24036580
[TBL] [Abstract][Full Text] [Related]
6. Non-criteria manifestations in primary antiphospholipid syndrome: a French multicenter retrospective cohort study.
Guédon AF; Catano J; Ricard L; Laurent C; de Moreuil C; Urbanski G; Deriaz S; Gerotziafas G; Elalamy I; Audemard A; Chasset F; Alamowitch S; Sellam J; Maillot F; Boffa JJ; Cohen A; Abisror N; Fain O; Mekinian A
Arthritis Res Ther; 2022 Jan; 24(1):33. PubMed ID: 35078523
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and Significance of Non-conventional Antiphospholipid Antibodies in Patients With Clinical APS Criteria.
Litvinova E; Darnige L; Kirilovsky A; Burnel Y; de Luna G; Dragon-Durey MA
Front Immunol; 2018; 9():2971. PubMed ID: 30619328
[No Abstract] [Full Text] [Related]
8. Pediatric catastrophic antiphospholipid syndrome: descriptive analysis of 45 patients from the "CAPS Registry".
Berman H; Rodríguez-Pintó I; Cervera R; Gregory S; de Meis E; Rodrigues CE; Aikawa NE; de Carvalho JF; Springer J; Niedzwiecki M; Espinosa G;
Autoimmun Rev; 2014 Feb; 13(2):157-62. PubMed ID: 24145009
[TBL] [Abstract][Full Text] [Related]
9. Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the "CAPS Registry".
Cervera R; Bucciarelli S; Plasín MA; Gómez-Puerta JA; Plaza J; Pons-Estel G; Shoenfeld Y; Ingelmo M; Espinos G;
J Autoimmun; 2009; 32(3-4):240-5. PubMed ID: 19324520
[TBL] [Abstract][Full Text] [Related]
10. Thrombocytopenia in high-risk patients with antiphospholipid syndrome.
Pontara E; Banzato A; Bison E; Cattini MG; Baroni G; Denas G; Calligaro A; Marson P; Tison T; Ruffatti A; Pengo V
J Thromb Haemost; 2018 Mar; 16(3):529-532. PubMed ID: 29316193
[TBL] [Abstract][Full Text] [Related]
11. Clinical features, risk factors, and outcomes of diffuse alveolar hemorrhage in antiphospholipid syndrome: A mixed-method approach combining a multicenter cohort with a systematic literature review.
Figueroa-Parra G; Meade-Aguilar JA; Langenfeld HE; González-Treviño M; Hocaoglu M; Hanson AC; Prokop LJ; Murad MH; Cartin-Ceba R; Specks U; Majithia V; Crowson CS; Duarte-García A
Clin Immunol; 2023 Nov; 256():109775. PubMed ID: 37722463
[TBL] [Abstract][Full Text] [Related]
12. The relative value of sociocultural and infrastructural adaptations to heat in a very hot climate in northern Australia: a case time series of heat-associated mortality.
Quilty S; Jupurrurla NF; Lal A; Matthews V; Gasparrini A; Hope P; Brearley M; Ebi KL
Lancet Planet Health; 2023 Aug; 7(8):e684-e693. PubMed ID: 37558349
[TBL] [Abstract][Full Text] [Related]
13. Pediatric antiphospholipid syndrome: clinical features and therapeutic interventions in a single center retrospective case series.
Madison JA; Gockman K; Hoy C; Tambralli A; Zuo Y; Knight JS
Pediatr Rheumatol Online J; 2022 Feb; 20(1):17. PubMed ID: 35197077
[TBL] [Abstract][Full Text] [Related]
14. Catastrophic Antiphospholipid Syndrome: A Complex Diagnosis in the Setting of Lupus.
Liang J; Mahmood R; Benchaala I; York R; Sarakbi H
Cureus; 2023 Aug; 15(8):e42922. PubMed ID: 37667720
[TBL] [Abstract][Full Text] [Related]
15. Aortitis is an under-recognized manifestation of antiphospholipid syndrome: A case report and literature review.
Escoda T; George J; Jarrot PA; Jean R; Mazodier K; Sanderson F; Poullin P; Saby L; Jourde-Chiche N; Kaplanski G; Chiche L
Lupus; 2022 May; 31(6):744-753. PubMed ID: 35341372
[TBL] [Abstract][Full Text] [Related]
16. Exploring the appropriateness of prescribing practice of inhaled pharmacotherapy among Aboriginal Australians in the Top End Northern Territory of Australia: a retrospective cohort study.
Heraganahally S; Howarth TP; Issac S; Lloyd A; Ravichandran SJ; Abeyaratne A; Patel B
BMJ Open Respir Res; 2023 Mar; 10(1):. PubMed ID: 36878611
[TBL] [Abstract][Full Text] [Related]
17. French National Diagnostic and Care Protocol for antiphospholipid syndrome in adults and children.
Amoura Z; Bader-Meunier B; Bal Dit Sollier C; Belot A; Benhamou Y; Bezanahary H; Cohen F; Costedoat-Chalumeau N; Darnige L; Drouet L; Elefant E; Harroche A; Lambert M; Martin T; Martin-Toutain I; Mathian A; Mekinian A; Pineton De Chambrun M; de Pontual L; Wahl D; Yelnik C; Zuily S;
Rev Med Interne; 2023 Sep; 44(9):495-520. PubMed ID: 37735010
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous Involvement in Catastrophic Antiphospholipid Syndrome in a Multicenter Cohort of 65 Patients.
Dupré A; Morel N; Yelnik C; Moguelet P; Le Guern V; Stammler R; Nguyen Y; Paule R; Dufrost V; Ackermann F; Benhamou Y; Godeau B; Lambert M; Duffau P; Mekinian A; Saadoun D; Mouthon L; Hachulla E; Maillard H; Levesque H; Morell-Dubois S; Leroux G; Piette JC; Chasset F; Costedoat-Chalumeau N
JAMA Dermatol; 2023 Jan; 159(1):62-67. PubMed ID: 36477813
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of Indigenous primary health care models of service delivery: a scoping review protocol.
Harfield S; Davy C; Kite E; McArthur A; Munn Z; Brown N; Brown A
JBI Database System Rev Implement Rep; 2015 Nov; 13(11):43-51. PubMed ID: 26657463
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulins and antiphospholipid syndrome: How, when and why? A review of the literature.
Tenti S; Cheleschi S; Guidelli GM; Galeazzi M; Fioravanti A
Autoimmun Rev; 2016 Mar; 15(3):226-35. PubMed ID: 26656906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
